Ryan Deschner Analyst Performance

Vice President, Equity Research- Biotech at Raymond James Financial

Ryan Deschner is a stock analyst at Raymond James Financial in the medical sector, covering 8 publicly traded companies. Over the past year, Ryan Deschner has issued 14 stock ratings, including strong buy, buy, and hold recommendations. While full access to Ryan Deschner's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Ryan Deschner's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 14 Last 0 Years
Buy Recommendations: 92.86% 13 Buy Ratings
Companies Covered: 8 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	57.1%	8 ratings
Buy	35.7%	5 ratings
Hold	7.1%	1 ratings
Sell	0.0%	0 ratings

Out of 14 total stock ratings issued by Ryan Deschner at Raymond James Financial, the majority (57.1%) have been Strong Buy recommendations, followed by 35.7% Buy and 7.1% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	100.0% of companies on NASDAQ	8 companies

Ryan Deschner, an analyst at Raymond James Financial, currently covers 8 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 8 companies	100.0%

Ryan Deschner of Raymond James Financial specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 7 companies	87.5%
MED - DRUGS 1 company	12.5%

About Ryan Deschner

Ryan Deschner joined Raymond James in 2018 as a research associate in the biotechnology sector. After receiving his Ph.D. in chemical engineering from the University of Texas at Austin, he helped launch nanoparticle-based startup, NanoHybrids, most recently serving as chief research officer. Prior to his graduate studies, he worked as a lithography engineer at IBM’s Semiconductor Research and Development Center. Ryan’s research in antibody sequencing, self-assembly, and advanced materials has led to 11 authored or co-authored publications and three issued patents.

Follow on LinkedIn

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
ARDX Ardelyx	9/3/2025	Initiated Coverage	$6.46	$14.00	Strong-Buy
ARDX Ardelyx	9/2/2025	Upgrade	$6.40		Strong-Buy
LQDA Liquidia Technologies	8/13/2025	Boost Price Target	$24.10	$41.00	Strong-Buy
TRVI Trevi Therapeutics	8/8/2025	Lower Price Target	$7.13	$27.00	Strong-Buy
PVLA Palvella Therapeutics	8/5/2025	Set Price Target	$37.52	$54.00	Outperform
ARDX Ardelyx	8/5/2025	Reiterated Rating	$5.08	$12.00	Outperform
APLS Apellis Pharmaceuticals	8/1/2025	Lower Price Target	$22.61	$50.00	Outperform
VKTX Viking Therapeutics	7/24/2025	Lower Price Target	$33.80	$122.00	Strong-Buy
TVRD Tvardi Therapeutics	7/14/2025	Initiated Coverage	$27.34	$62.00	Outperform
INZY Inozyme Pharma	5/16/2025	Reiterated Rating	$3.95	$4.00	Hold
APLS Apellis Pharmaceuticals	5/9/2025	Downgrade	$17.88	$52.00	Outperform
LQDA Liquidia Technologies	5/9/2025	Boost Price Target	$15.44	$29.00	Strong-Buy
TRVI Trevi Therapeutics	3/10/2025	Upgrade	$4.30	$29.00	Strong-Buy
ARDX Ardelyx	2/21/2025	Reiterated Rating	$5.29	$13.00	Strong-Buy

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.